Cargando…
Protein glycation – biomarkers of metabolic dysfunction and early-stage decline in health in the era of precision medicine
Protein glycation provides a biomarker in widespread clinical use, glycated hemoglobin HbA(1c) (A1C). It is a biomarker for diagnosis of diabetes and prediabetes and of medium-term glycemic control in patients with established diabetes. A1C is an early-stage glycation adduct of hemoglobin with gluco...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113047/ https://www.ncbi.nlm.nih.gov/pubmed/33707127 http://dx.doi.org/10.1016/j.redox.2021.101920 |